News OECD calls for 'rebalancing of power' in drug price negotiat... Health systems should fund more treatments for chronic diseases, says EFPIA
News New NICE rules could deny drugs to rare disease patients Patients could be denied treatments, says BIA
News Call for Roche to lower Kadcyla price further after NICE rej... Ruling could end funding for cancer drug in England.
News Use generic alternatives to Seretide and save millions, advi... Earlier use of montelukast could save NHS millions, says NICE.
News Pfizer fears rough ride with NICE over breast cancer drug Concerns over NICE's treatment of add-on therapies.
News MSD stops trials of BTK inhibitor for blood cancers MSD has stopped development of BTK inhibitor nemtabrutinib, acquired via its $2.7bn takeover of ArQule, after trial results pointed to a safety issue.
Sales & Marketing Sponsored Securing your ROI: Turning post-acquisition integration into... Join Forinnovia and Little Cube Consulting for a webinar on securing post-acquisition ROI.